Elligo sets up new partnership in Canada

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Motortion)
(Image: Getty/Motortion)

Related tags: Elligo Health Research

Elligo Health Research partners with Jack Nathan Health to provide clinical research as a care option to patients at its Walmart clinics in Canada.

The partnership further expands Elligo’s growing ‘Research Ready’ site network. The company earlier this year raised $20m in Series C funding​ to support the company’s goal of connecting physicians and their patients to clinical trials.

“This partnership bridges real world health care needs with the ever-increasing need for patient participation in clinical research,”​ said Eli Alford, vice president, global operations - research operations, Elligo Health Research.

“Uniquely, it brings innovative treatments directly to patients – through their trusted physician – effectively putting them at the center of the process, making participation convenient and comfortable, and ultimately increasing study enrollment and retention rates,”​ he told us.

Jack Nathan Health CEO George Barakat said the biggest benefit is to the patients, as the partnership improves access to clinical trials for two million patients annually at the clinic.

“It makes participating in research as care for their condition convenient and cost-effective,”​ Barakat told us.

“Beyond the patient benefits, JNH will have the opportunity to enhance its engagement and relationship with its patients by expanding its research capabilities without investing in a dedicated department,”​ he added. “The partnership will also help Elligo fulfill its mission to expand and diversify the patient pool and help sponsors bring better-quality products to market faster.”

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us


View more